当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer: less is more?
The Lancet Oncology ( IF 41.6 ) Pub Date : 2024-08-05 , DOI: 10.1016/s1470-2045(24)00397-8
Jeanine M L Roodhart 1 , Miriam Koopman 1
Affiliation  



中文翻译:


曲妥珠单抗 deruxtecan 治疗 HER2 阳性转移性结直肠癌:少即是多?


更新日期:2024-08-05
down
wechat
bug